These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
58 related articles for article (PubMed ID: 2941035)
21. Construction and characterization of a replication-defective herpes simplex virus 2 ICP8 mutant strain and its use in immunization studies in a guinea pig model of genital disease. Da Costa XJ; Bourne N; Stanberry LR; Knipe DM Virology; 1997 May; 232(1):1-12. PubMed ID: 9185583 [TBL] [Abstract][Full Text] [Related]
22. Analysis of the interferon status and cytokine profile in patients with genital herpes. Mezentseva MV; Narovlyansky AN; Scherbenko VE; Polonsky VO; Anokhina EY; Ershov FI Russ J Immunol; 2002 Jul; 7(2):167-74. PubMed ID: 12687260 [TBL] [Abstract][Full Text] [Related]
23. Immunity to herpes simplex virus type 2. V. Risk of recurrent disease following primary infection: modulation of T-cell subsets and lymphokine (LIF) production. Sheridan JF; Aurelian L Diagn Immunol; 1983; 1(3):245-56. PubMed ID: 6209056 [TBL] [Abstract][Full Text] [Related]
24. An update on short-course episodic and prevention therapies for herpes genitalis. Corey L; Bodsworth N; Mindel A; Patel R; Schacker T; Stanberry L Herpes; 2007 Jun; 14 Suppl 1():5A-11A. PubMed ID: 17877886 [TBL] [Abstract][Full Text] [Related]
25. Serologic and genotypic analysis of a series of herpes simplex virus type 1 isolates from two patients with genital herpes. Umene K; Kawana T; Fukumaki Y J Med Virol; 2009 Sep; 81(9):1605-12. PubMed ID: 19626604 [TBL] [Abstract][Full Text] [Related]
27. Virological, serological and epidemiological study of 255 consecutive cases of genital herpes in a sexually transmitted disease clinic of Paris (France): a prospective study. Janier M; Scieux C; Méouchi R; Tournoux C; Porcher R; Maillard A; Fouéré S; Taquin Y; Lassau F; Morel P Int J STD AIDS; 2006 Jan; 17(1):44-9. PubMed ID: 16409679 [TBL] [Abstract][Full Text] [Related]
28. Severe herpes virus (HSV-2) infection in two patients with myelodysplasia and undetectable NK cells and plasmacytoid dendritic cells in the blood. Dalloul A; Oksenhendler E; Chosidow O; Ribaud P; Carcelain G; Louvet S; Massip P; Lebon P; Autran B J Clin Virol; 2004 Aug; 30(4):329-36. PubMed ID: 15163423 [TBL] [Abstract][Full Text] [Related]
29. Seroprevalence and coinfection with herpes simplex virus type 1 and type 2 in the United States, 1988-1994. Xu F; Schillinger JA; Sternberg MR; Johnson RE; Lee FK; Nahmias AJ; Markowitz LE J Infect Dis; 2002 Apr; 185(8):1019-24. PubMed ID: 11930310 [TBL] [Abstract][Full Text] [Related]
36. Transfer factor in the treatment of herpes simplex types 1 and 2. Khan A; Hansen B; Hill NO; Loeb E; Pardue AS; Hill JM Dermatologica; 1981; 163(2):177-85. PubMed ID: 6974662 [TBL] [Abstract][Full Text] [Related]
37. Atypical Herpes Simplex Presenting Necrotizing Granulomas in an Immunocompromised Patient. Martinez-Mera C; Hospital M; López-Negrete E; Suarez Massa D Am J Dermatopathol; 2020 Apr; 42(4):305-306. PubMed ID: 31188142 [No Abstract] [Full Text] [Related]
38. Recurrent herpes genitalis, severe impairment of specific cell-mediated immune response and bilateral femoral head necrosis: report of a case. Sirianni MC; Soddu S; Bonomo R; Panà A Boll Ist Sieroter Milan; 1986; 65(1):78-83. PubMed ID: 2941035 [TBL] [Abstract][Full Text] [Related]
39. Immunological responses of patients with recurrent herpes genitalis. Sirianni MC; Bonomo R; Scarpati B; Soddu S; Panà A; Turbessi G; Cherchi M; Aiuti F Diagn Immunol; 1986; 4(6):294-8. PubMed ID: 3493109 [TBL] [Abstract][Full Text] [Related]
40. Coinfection with herpes simplex virus type 2 is associated with reduced HIV-specific T cell responses and systemic immune activation. Sheth PM; Sunderji S; Shin LY; Rebbapragada A; Huibner S; Kimani J; Macdonald KS; Ngugi E; Bwayo JJ; Moses S; Kovacs C; Loutfy M; Kaul R J Infect Dis; 2008 May; 197(10):1394-401. PubMed ID: 18444797 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]